首页 > 最新文献

BMC Neurology最新文献

英文 中文
Abnormalities along the cortico-medullary junction on brain MRI caused by 1,2-dichloroethane-induced toxic encephalopathy. 1,2-二氯乙烷诱发的中毒性脑病导致脑磁共振成像沿皮质-髓质交界处出现异常。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-15 DOI: 10.1186/s12883-024-03952-1
Dan Cai, Liqiang Kuang, Fan Hu, Yaoyao Shen

Background: 1,2-dichloroethane (DCE) induced toxic encephalopathy, a rare toxic disease of the central nervous system, is mainly reported in developing countries. Although clinicians have got some understanding about the clinical and neuroimaging features of 1,2-DCE-induced toxic encephalopathy, abnormality along the cortico-medullary junction on diffusion-weighted image (DWI) mimicking neuronal intranuclear inclusion disease (NIID) has not yet been described in this entity.

Case presentation: We reported a patient with 1,2-DCE-induced toxic encephalopathy who was admitted to our department due to a 7-day history of nausea, vomiting, and cognitive decline. Brain magnetic resonance imaging (MRI) showed symmetrical hyperintensities in bilateral subcortical white matte on T2-weghted and Fluid-attenuated inversion recovery (FLAIR) images. In addition, abnormal signal intensity could also be found in the cortico-medullary junction on DWI, mimicking NIID. After treated with glucocorticoid, dehydrating agents, neuroprotective agents, and hyperbaric oxygen, our patient received a partial recovery.

Conclusion: Our case highlights a special MRI finding-abnormalities along the cortico-medullary junction-that can be seen in 1,2-DCE-induced toxic encephalopathy. When confronted with patients with lesion located in the cortico-medullary junction and neuropsychiatric symptoms, our clinicians should not neglect the detailed inquiry of history of toxic exposure.

背景:1,2-二氯乙烷(DCE)诱发的中毒性脑病是一种罕见的中枢神经系统中毒性疾病,主要发生在发展中国家。尽管临床医生对 1,2-DCE 诱发的中毒性脑病的临床和神经影像学特征有了一定的了解,但在这一病例中,尚未发现弥散加权成像(DWI)上沿皮质-髓质交界处的异常可模拟神经元核内包涵体病(NIID):我们报告了一名 1,2-DCE 引起的中毒性脑病患者,该患者因恶心、呕吐和认知能力下降 7 天病史而入住我科。脑磁共振成像(MRI)显示,双侧皮层下白质在T2加厚和流体增强反转恢复(FLAIR)图像上出现对称性高密度。此外,在 DWI 上还发现皮质-髓质交界处信号强度异常,类似于 NIID。在接受糖皮质激素、脱水剂、神经保护剂和高压氧治疗后,我们的患者得到了部分康复:我们的病例凸显了 1,2-DCE 引发的中毒性脑病的一个特殊 MRI 发现--沿皮质-髓质交界处的异常。面对皮质-髓质交界处病变并伴有神经精神症状的患者,我们的临床医生不应忽视对中毒接触史的详细询问。
{"title":"Abnormalities along the cortico-medullary junction on brain MRI caused by 1,2-dichloroethane-induced toxic encephalopathy.","authors":"Dan Cai, Liqiang Kuang, Fan Hu, Yaoyao Shen","doi":"10.1186/s12883-024-03952-1","DOIUrl":"10.1186/s12883-024-03952-1","url":null,"abstract":"<p><strong>Background: </strong>1,2-dichloroethane (DCE) induced toxic encephalopathy, a rare toxic disease of the central nervous system, is mainly reported in developing countries. Although clinicians have got some understanding about the clinical and neuroimaging features of 1,2-DCE-induced toxic encephalopathy, abnormality along the cortico-medullary junction on diffusion-weighted image (DWI) mimicking neuronal intranuclear inclusion disease (NIID) has not yet been described in this entity.</p><p><strong>Case presentation: </strong>We reported a patient with 1,2-DCE-induced toxic encephalopathy who was admitted to our department due to a 7-day history of nausea, vomiting, and cognitive decline. Brain magnetic resonance imaging (MRI) showed symmetrical hyperintensities in bilateral subcortical white matte on T2-weghted and Fluid-attenuated inversion recovery (FLAIR) images. In addition, abnormal signal intensity could also be found in the cortico-medullary junction on DWI, mimicking NIID. After treated with glucocorticoid, dehydrating agents, neuroprotective agents, and hyperbaric oxygen, our patient received a partial recovery.</p><p><strong>Conclusion: </strong>Our case highlights a special MRI finding-abnormalities along the cortico-medullary junction-that can be seen in 1,2-DCE-induced toxic encephalopathy. When confronted with patients with lesion located in the cortico-medullary junction and neuropsychiatric symptoms, our clinicians should not neglect the detailed inquiry of history of toxic exposure.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"447"},"PeriodicalIF":2.2,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11566381/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142643314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highly prevalent geriatric medications and their effect on β-amyloid fibril formation. 高发老年药物及其对 β 淀粉样蛋白纤维形成的影响。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-14 DOI: 10.1186/s12883-024-03930-7
Zakia Zaman, Radia Islam, Bhavya Koganti, Vaibhavkumar Falki, Tammy Osentoski, Stewart Graham, Md Golam Sharoar
<p><strong>Background: </strong>The unprecedented increase in the older population and ever-increasing incidence of dementia are leading to a "silver tsunami" in upcoming decades. To combat multimorbidity and maintain daily activities, elderly people face a high prevalence of polypharmacy. However, how these medications affect dementia-related pathology, such as Alzheimer's β-amyloid (Aβ) fibrils formation, remains unknown. In the present study, we aimed to analyze the medication profiles of Alzheimer's disease (AD; n = 124), mild cognitive impairment (MCI; n = 114), and non-demented (ND; n = 228) patients to identify highly prevalent drugs and to determine the effects of those drugs on Aβ fibrils formation.</p><p><strong>Methods: </strong>Study subjects (≥ 65 years) were recruited from an academic geriatric practice that heavily focuses on memory disorders. The disease state was defined based on the score of multiple cognitive assessments. Individual medications for each subject were listed and categorized into 10 major drug classes. Statistical analysis was performed to determine the frequency of individual and collective drug classes, which are expressed as percentages of the respective cohorts. 10 µM monomeric β-amyloid (Aβ) 42 and fibrillar Aβ (fAβ) were incubated for 6-48 h in the presence of 25 µM drugs. fAβ was prepared with a 1:10 ratio of Aβ42 to Aβ40. The amount of Aβ fibrils was monitored using a thioflavin T (Th-T) assay. Neuronal cells (N2A and SHSY-5Y) were treated with 25 µM drugs, and cell death was measured using a lactose dehydrogenase (LDH) assay.</p><p><strong>Results: </strong>We noticed a high prevalence (82-90%) of polypharmacy and diverse medication profiles including anti-inflammatory (65-77%), vitamin and mineral (64-72%), anti-cholesterol (33-41%), anti-hypersensitive (35-39%), proton pump inhibitor (23-34%), anti-thyroid (9-21%), anti-diabetic (5-13%), anti-constipation (9-11%), anti-coagulant (10-13%), and anti-insomnia (9-20%) drugs in the three cohorts. Our LDH assay with 18 highly prevalent drug components showed toxic effects of Norvasc, Tylenol, Colace, and Plavix on N2A cells, and of vitamin D and Novasc on SH-SY5Y cells. All these drugs except Colace significantly reduced the amount of Aβ fibril when incubated with Aβ42 for a short period (6 h). However, Lipitor, vitamin D, Levothyroxine, Prilosec, Flomax, and Norvasc prominently reduce the amount of fibrils when incubated with monomeric Aβ42 for a longer period (48 h). Furthermore, our disaggregation study with fAβ showed consistent results for cholecalciferol (vitamin D), omeprazole (Prilosec), clopidogrel hydrogensulfate (Flomax), levothyroxine, and amlodipine (Norvasc). The chemical structures of these four efficient molecules contain polyphenol components, a characteristic feature of the structures of polyphenolic inhibitors of Aβ fibrillation.</p><p><strong>Conclusion: </strong>A higher polypharmacy incidence was observed in an elderly population of 228
背景:老年人口的空前增长和痴呆症发病率的不断上升正在导致未来几十年的 "银发海啸"。为了应对多发病和维持日常活动,老年人面临着多种药物的高发病率。然而,这些药物如何影响痴呆症相关病理,如阿尔茨海默氏症β淀粉样蛋白(Aβ)纤维的形成,仍是一个未知数。在本研究中,我们旨在分析阿尔茨海默病(AD;n = 124)、轻度认知障碍(MCI;n = 114)和非痴呆(ND;n = 228)患者的用药情况,以确定高发药物,并确定这些药物对 Aβ 纤维形成的影响:研究对象(≥ 65 岁)来自一家主要研究记忆障碍的老年医学学术机构。疾病状态根据多项认知评估的得分确定。每个受试者的个人用药被列出并分为 10 大类药物。统计分析确定了单个药物类别和集体药物类别的频率,并以各自组群的百分比表示。10 µM 单体β淀粉样蛋白(Aβ)42 和纤维状 Aβ(fAβ)在 25 µM 药物存在下孵育 6-48 小时。用硫黄素 T(Th-T)检测法监测 Aβ 纤维的数量。用 25 µM 药物处理神经元细胞(N2A 和 SHSY-5Y),并用乳糖脱氢酶(LDH)测定法检测细胞死亡情况:在三个队列中,抗胆固醇药(33%-41%)、抗高血压药(35%-39%)、抗质子泵抑制剂药(23%-34%)、抗甲状腺药(9%-21%)、抗糖尿病药(5%-13%)、抗便秘药(9%-11%)、抗凝血药(10%-13%)和抗失眠药(9%-20%)的比例最高。我们用 18 种高发药物成分进行的 LDH 检测显示,Norvasc、泰诺、可乐定和 Plavix 对 N2A 细胞有毒性作用,维生素 D 和 Novasc 对 SH-SY5Y 细胞有毒性作用。在与 Aβ42 短时间(6 小时)培养后,除可乐定外,所有这些药物都能明显减少 Aβ 纤维的数量。然而,当与单体 Aβ42 培养较长时间(48 小时)时,立普妥、维生素 D、左旋甲状腺素、普利洛司克、氟美司和诺伐司克会明显减少纤维的数量。此外,我们用 fAβ 进行的分解研究显示,胆卡西醇(维生素 D)、奥美拉唑(普利洛赛克)、氢化硫酸氯吡格雷(氟美松)、左旋甲状腺素和氨氯地平(诺伐西汀)的分解结果一致。这四种高效分子的化学结构中都含有多酚成分,这也是Aβ纤颤多酚抑制剂结构的一个特点:在 228 名 ND、114 名 MCI 和 124 名 AD 患者的老年人群中,我们观察到了较高的多药滥用率。我们发现,包括维生素 D3、左甲状腺素、普利洛司、氟美司和 Norvasc 在内的几种强烈推荐的药物成分能在体外有效减少由单体 Aβ42 和现有已形成的 Aβ 纤维形成的纤维数量。然而,只有左甲状腺素能够防止 Aβ 介导的对 SH-SY5Y 细胞的毒性。我们的研究表明,这些药物可能具有多酚抑制剂 Aβ 的功能。
{"title":"Highly prevalent geriatric medications and their effect on β-amyloid fibril formation.","authors":"Zakia Zaman, Radia Islam, Bhavya Koganti, Vaibhavkumar Falki, Tammy Osentoski, Stewart Graham, Md Golam Sharoar","doi":"10.1186/s12883-024-03930-7","DOIUrl":"10.1186/s12883-024-03930-7","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The unprecedented increase in the older population and ever-increasing incidence of dementia are leading to a \"silver tsunami\" in upcoming decades. To combat multimorbidity and maintain daily activities, elderly people face a high prevalence of polypharmacy. However, how these medications affect dementia-related pathology, such as Alzheimer's β-amyloid (Aβ) fibrils formation, remains unknown. In the present study, we aimed to analyze the medication profiles of Alzheimer's disease (AD; n = 124), mild cognitive impairment (MCI; n = 114), and non-demented (ND; n = 228) patients to identify highly prevalent drugs and to determine the effects of those drugs on Aβ fibrils formation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Study subjects (≥ 65 years) were recruited from an academic geriatric practice that heavily focuses on memory disorders. The disease state was defined based on the score of multiple cognitive assessments. Individual medications for each subject were listed and categorized into 10 major drug classes. Statistical analysis was performed to determine the frequency of individual and collective drug classes, which are expressed as percentages of the respective cohorts. 10 µM monomeric β-amyloid (Aβ) 42 and fibrillar Aβ (fAβ) were incubated for 6-48 h in the presence of 25 µM drugs. fAβ was prepared with a 1:10 ratio of Aβ42 to Aβ40. The amount of Aβ fibrils was monitored using a thioflavin T (Th-T) assay. Neuronal cells (N2A and SHSY-5Y) were treated with 25 µM drugs, and cell death was measured using a lactose dehydrogenase (LDH) assay.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;We noticed a high prevalence (82-90%) of polypharmacy and diverse medication profiles including anti-inflammatory (65-77%), vitamin and mineral (64-72%), anti-cholesterol (33-41%), anti-hypersensitive (35-39%), proton pump inhibitor (23-34%), anti-thyroid (9-21%), anti-diabetic (5-13%), anti-constipation (9-11%), anti-coagulant (10-13%), and anti-insomnia (9-20%) drugs in the three cohorts. Our LDH assay with 18 highly prevalent drug components showed toxic effects of Norvasc, Tylenol, Colace, and Plavix on N2A cells, and of vitamin D and Novasc on SH-SY5Y cells. All these drugs except Colace significantly reduced the amount of Aβ fibril when incubated with Aβ42 for a short period (6 h). However, Lipitor, vitamin D, Levothyroxine, Prilosec, Flomax, and Norvasc prominently reduce the amount of fibrils when incubated with monomeric Aβ42 for a longer period (48 h). Furthermore, our disaggregation study with fAβ showed consistent results for cholecalciferol (vitamin D), omeprazole (Prilosec), clopidogrel hydrogensulfate (Flomax), levothyroxine, and amlodipine (Norvasc). The chemical structures of these four efficient molecules contain polyphenol components, a characteristic feature of the structures of polyphenolic inhibitors of Aβ fibrillation.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;A higher polypharmacy incidence was observed in an elderly population of 228 ","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"445"},"PeriodicalIF":2.2,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562802/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A patient with P369S/R408Q variants in the MEFV gene presented with clinical features of Kikuchi disease and Mollaret meningitis, successfully treated with colchicine. 一名 MEFV 基因 P369S/R408Q 变体患者出现菊池病和莫拉雷特脑膜炎的临床特征,使用秋水仙碱治疗后获得成功。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-14 DOI: 10.1186/s12883-024-03950-3
Hideo Handa, Atsuhiko Sugiyama, Hitoshi Kubosawa, Yuki Nakagawa, Dai Kishida, Akiyuki Uzawa, Akiyo Aotsuka, Satoshi Kuwabara

Background: This case report presents the case of a patient with P369S and R408Q variants in the MEFV gene who exhibited clinical features of Kikuchi disease and Mollaret meningitis. Furthermore, it discusses colchicine as a new potential treatment option for Kikuchi disease-associated meningitis.

Case presentation: A 41-year-old Japanese woman presented with fever and headache. She had nuchal rigidity and bilateral cervical lymphadenopathies. Her past medical history included multiple episodes of aseptic meningitis and cervical lymphadenopathy for more than twenty years. Lumbar puncture showed increased lymphocytes and IL-6 level and pathognomonic Mollaret cells. Excisional lymph node biopsy revealed histiocytic necrotizing lymphadenitis, confirming the diagnosis of Kikuchi disease. Subsequently, her recurrent Kikuchi disease and meningitis were successfully treated with colchicine. Furthermore, genetic analysis of the MEFV gene revealed heterozygous P369S/R408Q variants in exon 3.

Conclusion: Mollaret meningitis can be associated with Kikuchi disease, and recurrence of both conditions may be suppressed by colchicine when these two coexist.

背景:本病例报告了一例 MEFV 基因 P369S 和 R408Q 变体患者,该患者表现出菊池病和 Mollaret 脑膜炎的临床特征。此外,报告还讨论了秋水仙碱作为菊池病相关性脑膜炎的一种新的潜在治疗方案:病例介绍:一名 41 岁的日本妇女因发烧和头痛前来就诊。她有颈部僵硬和双侧颈淋巴结病。她的既往病史包括 20 多年来多次发作的无菌性脑膜炎和颈淋巴结病。腰椎穿刺显示淋巴细胞和IL-6水平升高,并出现病理特征性的Mollaret细胞。淋巴结切除活检显示组织细胞坏死性淋巴结炎,确诊为菊池病。随后,她用秋水仙碱成功治疗了复发性菊池病和脑膜炎。此外,对 MEFV 基因的遗传分析表明,该基因第 3 外显子存在 P369S/R408Q 变异:结论:莫拉雷特脑膜炎可能与菊地病有关,当这两种疾病同时存在时,秋水仙碱可抑制这两种疾病的复发。
{"title":"A patient with P369S/R408Q variants in the MEFV gene presented with clinical features of Kikuchi disease and Mollaret meningitis, successfully treated with colchicine.","authors":"Hideo Handa, Atsuhiko Sugiyama, Hitoshi Kubosawa, Yuki Nakagawa, Dai Kishida, Akiyuki Uzawa, Akiyo Aotsuka, Satoshi Kuwabara","doi":"10.1186/s12883-024-03950-3","DOIUrl":"10.1186/s12883-024-03950-3","url":null,"abstract":"<p><strong>Background: </strong>This case report presents the case of a patient with P369S and R408Q variants in the MEFV gene who exhibited clinical features of Kikuchi disease and Mollaret meningitis. Furthermore, it discusses colchicine as a new potential treatment option for Kikuchi disease-associated meningitis.</p><p><strong>Case presentation: </strong>A 41-year-old Japanese woman presented with fever and headache. She had nuchal rigidity and bilateral cervical lymphadenopathies. Her past medical history included multiple episodes of aseptic meningitis and cervical lymphadenopathy for more than twenty years. Lumbar puncture showed increased lymphocytes and IL-6 level and pathognomonic Mollaret cells. Excisional lymph node biopsy revealed histiocytic necrotizing lymphadenitis, confirming the diagnosis of Kikuchi disease. Subsequently, her recurrent Kikuchi disease and meningitis were successfully treated with colchicine. Furthermore, genetic analysis of the MEFV gene revealed heterozygous P369S/R408Q variants in exon 3.</p><p><strong>Conclusion: </strong>Mollaret meningitis can be associated with Kikuchi disease, and recurrence of both conditions may be suppressed by colchicine when these two coexist.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"446"},"PeriodicalIF":2.2,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between reticulospinal system sensitization and proprioceptive pathways in the development of dynamic spasticity (ReProDS) post-spinal cord injury: protocol for a prospective, observational cohort study. 脊髓损伤后动态痉挛(ReProDS)发展过程中网状脊髓系统敏感化与本体感觉通路之间的关系:前瞻性观察队列研究方案。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12883-024-03947-y
Jingrong Wang, Lianghua Fan, Jing Sun, Jibao Chen, Ying Wang, ZengQiang OuYang, Zhihong Yuan, Changqin Sun, Lingjing Jin, Yue Wang

Background: Dynamic spasticity (DS) is a common complication post-spinal cord injury (SCI), marked by intermittent increases in muscle tone during postural transitions or movement. Despite its prevalence, high-quality research on DS incidence, risk factors, and underlying mechanisms in SCI patients remains limited. With the growing application of spinal cord stimulation (SCS) for spasticity control, the role of proprioception in DS development has garnered attention. Additionally, advances in diffusion tensor imaging (DTI) allow for the analysis of the reticulospinal tract's (RST) role in postural control among SCI patients. However, the impact of microstructural changes in RST and proprioception on DS following SCI remains unclear.

Objective: To investigate the relationship between microstructural changes in the RST and proprioceptive circuits in SCI patients, exploring their association with DS and potential predictive factors that influence recovery.

Methods: This is a 12-month prospective cohort study. The neurophysiological and global functional status of the participants will be assessed. Primary outcomes include DTI indices of RST and proprioception, and spasticity assessment. Secondary outcomes include auditory startle reflex (ASR), H-reflex, shear wave velocity (SWV), overall functional status including spinal cord independence measure, gait analysis, modified Barthel Index, and the 36-item short form health survey. Data will be collected at 1, 3, 6, and 12 months after enrolment. Matched healthy controls will be measured during the same period after recruitment.

Discussion: This study is the first to explore the role of microstructural changes in the RST and proprioception in the assessment and prediction of DS following SCI. The findings aim to enhance theoretical understanding of SCS in spasticity management and to establish pre-treatment criteria for SCS interventions targeting motor function recovery in SCI.

Trial registration number: ChiCTR2400090724.

背景:动态痉挛(Dynamic spasticity,DS)是脊髓损伤(SCI)后的一种常见并发症,表现为体位转换或运动时肌肉张力间歇性增加。尽管其发病率很高,但有关脊髓损伤患者动态痉挛发生率、风险因素和潜在机制的高质量研究仍然有限。随着脊髓刺激(SCS)在痉挛控制中的应用日益广泛,本体感觉在 DS 发生过程中的作用已引起人们的关注。此外,弥散张量成像(DTI)技术的进步也有助于分析网状脊髓束(RST)在 SCI 患者姿势控制中的作用。然而,RST 的微结构变化和本体感觉对 SCI 后 DS 的影响仍不清楚:调查 SCI 患者 RST 和本体感觉回路微结构变化之间的关系,探讨它们与 DS 的关联以及影响恢复的潜在预测因素:这是一项为期 12 个月的前瞻性队列研究。方法:这是一项为期 12 个月的前瞻性队列研究,将对参与者的神经生理和整体功能状态进行评估。主要结果包括 RST 和本体感觉的 DTI 指数以及痉挛评估。次要结果包括听觉惊跳反射(ASR)、H反射、剪切波速度(SWV)、整体功能状态(包括脊髓独立性测量)、步态分析、改良巴特尔指数和 36 项简表健康调查。数据将在入组 1、3、6 和 12 个月后收集。在招募后的同一时期,将对匹配的健康对照组进行测量:本研究首次探讨了 RST 和本体感觉的微观结构变化在 SCI 后 DS 的评估和预测中的作用。研究结果旨在加强理论界对SCS治疗痉挛的理解,并为针对SCI运动功能恢复的SCS干预建立治疗前标准:试验注册号:ChiCTR2400090724。
{"title":"Relationship between reticulospinal system sensitization and proprioceptive pathways in the development of dynamic spasticity (ReProDS) post-spinal cord injury: protocol for a prospective, observational cohort study.","authors":"Jingrong Wang, Lianghua Fan, Jing Sun, Jibao Chen, Ying Wang, ZengQiang OuYang, Zhihong Yuan, Changqin Sun, Lingjing Jin, Yue Wang","doi":"10.1186/s12883-024-03947-y","DOIUrl":"10.1186/s12883-024-03947-y","url":null,"abstract":"<p><strong>Background: </strong>Dynamic spasticity (DS) is a common complication post-spinal cord injury (SCI), marked by intermittent increases in muscle tone during postural transitions or movement. Despite its prevalence, high-quality research on DS incidence, risk factors, and underlying mechanisms in SCI patients remains limited. With the growing application of spinal cord stimulation (SCS) for spasticity control, the role of proprioception in DS development has garnered attention. Additionally, advances in diffusion tensor imaging (DTI) allow for the analysis of the reticulospinal tract's (RST) role in postural control among SCI patients. However, the impact of microstructural changes in RST and proprioception on DS following SCI remains unclear.</p><p><strong>Objective: </strong>To investigate the relationship between microstructural changes in the RST and proprioceptive circuits in SCI patients, exploring their association with DS and potential predictive factors that influence recovery.</p><p><strong>Methods: </strong>This is a 12-month prospective cohort study. The neurophysiological and global functional status of the participants will be assessed. Primary outcomes include DTI indices of RST and proprioception, and spasticity assessment. Secondary outcomes include auditory startle reflex (ASR), H-reflex, shear wave velocity (SWV), overall functional status including spinal cord independence measure, gait analysis, modified Barthel Index, and the 36-item short form health survey. Data will be collected at 1, 3, 6, and 12 months after enrolment. Matched healthy controls will be measured during the same period after recruitment.</p><p><strong>Discussion: </strong>This study is the first to explore the role of microstructural changes in the RST and proprioception in the assessment and prediction of DS following SCI. The findings aim to enhance theoretical understanding of SCS in spasticity management and to establish pre-treatment criteria for SCS interventions targeting motor function recovery in SCI.</p><p><strong>Trial registration number: </strong>ChiCTR2400090724.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"440"},"PeriodicalIF":2.2,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Burden of Parkinson's disease in Central Asia from 1990 to 2021: findings from the Global Burden of Disease study. 1990 至 2021 年中亚帕金森病的负担:全球疾病负担研究的结果。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12883-024-03949-w
Ruslan Akhmedullin, Adil Supiyev, Rauan Kaiyrzhanov, Alpamys Issanov, Abduzhappar Gaipov, Antonio Sarria-Santamera, Raushan Tautanova, Byron Crape

Background: Central Asia is known to face various ecological challenges that constitutes major risk factors for Parkinson's disease (PD). This study examines the burden of PD in Central Asia, a region where data on neurological disorders is notably sparse.

Methods: Building on the latest Global Burden of Disease Study (GBD 2021), this study investigates the Years of Life Lost (YLLs), Years Lived with Disability (YLDs), and Disability-Adjusted Life Years (DALYs) associated with PD in Central Asia and its countries from 1990 to 2021. The authors calculated average annual percent change (AAPC) to analyze trends, and compared individual country estimates to global figures. Additionally, incorporating data from the World Bank, both Bayesian hierarchical and non-hierarchical frequentist regression models were employed to assess their impact on DALYs.

Results: The DALYs varied across the study period, primarily driven by YLLs. While YLLs showed a uniform trend, YLDs were mostly incremental. Kazakhstan had the highest estimates across all metrics and was the only country aligned with global patterns. Age- and sex-specific estimates revealed substantial variations, with notably high figures found in male subjects from Tajikistan. The YLLs, YLDs, and DALYs for Kazakhstan, Uzbekistan, and Turkmenistan saw a significant increase in AAPCs. In contrast, Kyrgyzstan and Tajikistan saw declines, likely attributable to civic conflict and inter-country differences in population structure. Further comparison of DALY trends revealed significant deviations for all countries from the global pattern.

Conclusion: This study showed an overall increase in PD burden from 1990 to 2021. These findings underscore the need for targeted strategies to reduce PD burden, with a particular focus on Kazakhstan. Integrating historical information is crucial for discussing the plausible mechanisms in studies sourced from the GBD.

背景:众所周知,中亚地区面临着各种生态挑战,这些挑战构成了帕金森病(PD)的主要风险因素。本研究探讨了中亚地区帕金森病的负担,因为该地区神经系统疾病的数据非常稀少:本研究以最新的全球疾病负担研究(GBD 2021)为基础,调查了 1990 年至 2021 年中亚及其国家与帕金森病相关的生命损失年数(YLLs)、残疾生存年数(YLDs)和残疾调整生命年数(DALYs)。作者计算了年均百分比变化 (AAPC) 以分析趋势,并将各个国家的估计值与全球数字进行了比较。此外,结合世界银行的数据,作者还采用了贝叶斯分层和非分层频数回归模型来评估其对残疾调整寿命年数的影响:在整个研究期间,残疾调整寿命年数各不相同,主要受年均生命周期的影响。虽然 YLLs 显示出统一的趋势,但 YLDs 大多是递增的。在所有指标中,哈萨克斯坦的估计值最高,是唯一一个与全球模式一致的国家。针对不同年龄和性别的估计值显示出巨大差异,塔吉克斯坦男性受试者的估计值尤其高。在哈萨克斯坦、乌兹别克斯坦和土库曼斯坦,AAPC 的 YLLs、YLDs 和 DALYs 显著增加。相比之下,吉尔吉斯斯坦和塔吉克斯坦则有所下降,这可能是由于国内冲突和国家间人口结构的差异造成的。对残疾调整寿命年数趋势的进一步比较显示,所有国家都明显偏离了全球模式:这项研究表明,从 1990 年到 2021 年,PD 负担总体上有所增加。这些研究结果表明,有必要制定有针对性的战略,以减少帕金森病的负担,特别是在哈萨克斯坦。整合历史信息对于讨论源自《全球疾病报告》的研究中的合理机制至关重要。
{"title":"Burden of Parkinson's disease in Central Asia from 1990 to 2021: findings from the Global Burden of Disease study.","authors":"Ruslan Akhmedullin, Adil Supiyev, Rauan Kaiyrzhanov, Alpamys Issanov, Abduzhappar Gaipov, Antonio Sarria-Santamera, Raushan Tautanova, Byron Crape","doi":"10.1186/s12883-024-03949-w","DOIUrl":"10.1186/s12883-024-03949-w","url":null,"abstract":"<p><strong>Background: </strong>Central Asia is known to face various ecological challenges that constitutes major risk factors for Parkinson's disease (PD). This study examines the burden of PD in Central Asia, a region where data on neurological disorders is notably sparse.</p><p><strong>Methods: </strong>Building on the latest Global Burden of Disease Study (GBD 2021), this study investigates the Years of Life Lost (YLLs), Years Lived with Disability (YLDs), and Disability-Adjusted Life Years (DALYs) associated with PD in Central Asia and its countries from 1990 to 2021. The authors calculated average annual percent change (AAPC) to analyze trends, and compared individual country estimates to global figures. Additionally, incorporating data from the World Bank, both Bayesian hierarchical and non-hierarchical frequentist regression models were employed to assess their impact on DALYs.</p><p><strong>Results: </strong>The DALYs varied across the study period, primarily driven by YLLs. While YLLs showed a uniform trend, YLDs were mostly incremental. Kazakhstan had the highest estimates across all metrics and was the only country aligned with global patterns. Age- and sex-specific estimates revealed substantial variations, with notably high figures found in male subjects from Tajikistan. The YLLs, YLDs, and DALYs for Kazakhstan, Uzbekistan, and Turkmenistan saw a significant increase in AAPCs. In contrast, Kyrgyzstan and Tajikistan saw declines, likely attributable to civic conflict and inter-country differences in population structure. Further comparison of DALY trends revealed significant deviations for all countries from the global pattern.</p><p><strong>Conclusion: </strong>This study showed an overall increase in PD burden from 1990 to 2021. These findings underscore the need for targeted strategies to reduce PD burden, with a particular focus on Kazakhstan. Integrating historical information is crucial for discussing the plausible mechanisms in studies sourced from the GBD.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"444"},"PeriodicalIF":2.2,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558836/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614941","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoimmune encephalitis with coexisting antibodies to GABABR, GAD65, SOX1 and Ma2. 自身免疫性脑炎,同时存在 GABABR、GAD65、SOX1 和 Ma2 抗体。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12883-024-03938-z
Pankui Li, Tingting Yang, Yixin Gu, Jing Zhou, Zhenhai Wang

Background: Autoimmune encephalitis (AE) is a disease caused by an abnormal reaction between the body's autoimmunity and the central nervous system, in which the abnormal immune response targets antigenic components within or on the surface of neuronal cells. The main manifestations are mental and behavioural changes, cognitive impairment, impaired consciousness, seizures, movement disorders, etc. Most cell surface antibodies respond well to immunotherapy, intracellular antibodies, on the other hand, are usually associated with more tumours and are relatively difficult to treat with a poor prognosis. In recent years, autoimmune encephalitis that is positive for multiple anti-neuronal antibodies has been gradually recognized in the clinic, with complex and varied clinical manifestations, especially in combination with malignant tumours, which have worse treatment and prognosis. Current clinical studies on the coexistence of multiple anti-neuronal antibodies in patients with AE are mainly disseminated case reports. Patients with AE in which four anti-neuronal antibodies coexist are even rarer.

Case presentation: We report a patient who initially presented with an irritating dry cough and hyponatraemia and a chest CT suspicious for malignancy, followed by progressive deterioration of persistent status epilepticus, consciousness and cognitive deficits, and psycho-behavioural abnormalities. Serum and cerebrospinal fluid antibodies against neuronal surface or intracellular antigens were detected using a cell-based assay (CBA) method. Serum and cerebrospinal fluid were found to be positive for anti-GABABR, GAD65, SOX1 and Ma2 antibodies. And a definitive diagnosis of small cell lung cancer was made by immunohistochemistry. He eventually received gammaglobulin, steroid pulsed therapy and tumour chemotherapy.

Conclusions: The coexistence or overlap of multiple anti-neuronal surface antibodies with anti-neuronal intracellular antibodies is rare and increases the likelihood of underlying malignancy. Elucidating the impact of individualized immunotherapy and coexisting antibodies on the clinical presentation of patients has the potential to improve long-term prognosis.

背景:自身免疫性脑炎(AE)是一种由机体自身免疫与中枢神经系统之间的异常反应引起的疾病,异常免疫反应针对神经元细胞内或表面的抗原成分。主要表现为精神和行为改变、认知障碍、意识障碍、癫痫发作、运动障碍等。大多数细胞表面抗体对免疫疗法反应良好,而细胞内抗体通常伴有较多肿瘤,治疗相对困难,预后较差。近年来,临床上逐渐认识到多种抗神经元抗体阳性的自身免疫性脑炎,其临床表现复杂多样,尤其是合并恶性肿瘤时,治疗和预后更差。目前关于AE患者同时存在多种抗神经元抗体的临床研究主要是散见的病例报告。同时存在四种抗神经元抗体的AE患者更是罕见:我们报告了一名患者,该患者最初表现为刺激性干咳和低钠血症,胸部 CT 怀疑为恶性肿瘤,随后病情逐渐恶化,出现癫痫持续状态、意识和认知障碍以及精神行为异常。采用细胞检测法(CBA)检测血清和脑脊液中针对神经元表面或细胞内抗原的抗体。发现血清和脑脊液中抗-GABABR、GAD65、SOX1和Ma2抗体呈阳性。免疫组化明确诊断为小细胞肺癌。他最终接受了丙种球蛋白、类固醇脉冲疗法和肿瘤化疗:结论:多种抗神经元表面抗体与抗神经元细胞内抗体并存或重叠的情况非常罕见,会增加潜在恶性肿瘤的可能性。阐明个体化免疫治疗和共存抗体对患者临床表现的影响,有可能改善长期预后。
{"title":"Autoimmune encephalitis with coexisting antibodies to GABABR, GAD65, SOX1 and Ma2.","authors":"Pankui Li, Tingting Yang, Yixin Gu, Jing Zhou, Zhenhai Wang","doi":"10.1186/s12883-024-03938-z","DOIUrl":"10.1186/s12883-024-03938-z","url":null,"abstract":"<p><strong>Background: </strong>Autoimmune encephalitis (AE) is a disease caused by an abnormal reaction between the body's autoimmunity and the central nervous system, in which the abnormal immune response targets antigenic components within or on the surface of neuronal cells. The main manifestations are mental and behavioural changes, cognitive impairment, impaired consciousness, seizures, movement disorders, etc. Most cell surface antibodies respond well to immunotherapy, intracellular antibodies, on the other hand, are usually associated with more tumours and are relatively difficult to treat with a poor prognosis. In recent years, autoimmune encephalitis that is positive for multiple anti-neuronal antibodies has been gradually recognized in the clinic, with complex and varied clinical manifestations, especially in combination with malignant tumours, which have worse treatment and prognosis. Current clinical studies on the coexistence of multiple anti-neuronal antibodies in patients with AE are mainly disseminated case reports. Patients with AE in which four anti-neuronal antibodies coexist are even rarer.</p><p><strong>Case presentation: </strong>We report a patient who initially presented with an irritating dry cough and hyponatraemia and a chest CT suspicious for malignancy, followed by progressive deterioration of persistent status epilepticus, consciousness and cognitive deficits, and psycho-behavioural abnormalities. Serum and cerebrospinal fluid antibodies against neuronal surface or intracellular antigens were detected using a cell-based assay (CBA) method. Serum and cerebrospinal fluid were found to be positive for anti-GABABR, GAD65, SOX1 and Ma2 antibodies. And a definitive diagnosis of small cell lung cancer was made by immunohistochemistry. He eventually received gammaglobulin, steroid pulsed therapy and tumour chemotherapy.</p><p><strong>Conclusions: </strong>The coexistence or overlap of multiple anti-neuronal surface antibodies with anti-neuronal intracellular antibodies is rare and increases the likelihood of underlying malignancy. Elucidating the impact of individualized immunotherapy and coexisting antibodies on the clinical presentation of patients has the potential to improve long-term prognosis.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"441"},"PeriodicalIF":2.2,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11559185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Factors associated with mortality and functional outcome after decompressive craniectomy in malignant middle cerebral artery infarction. 更正:恶性大脑中动脉梗死减压开颅术后死亡率和功能预后的相关因素。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12883-024-03957-w
Jun Shen, Qian An, Shaolin Zhang, Ruixiang Ge, Dongdong Sun, Jun Cao, Jingcheng Fang, Dayong Xia, Xiaochun Jiang
{"title":"Correction: Factors associated with mortality and functional outcome after decompressive craniectomy in malignant middle cerebral artery infarction.","authors":"Jun Shen, Qian An, Shaolin Zhang, Ruixiang Ge, Dongdong Sun, Jun Cao, Jingcheng Fang, Dayong Xia, Xiaochun Jiang","doi":"10.1186/s12883-024-03957-w","DOIUrl":"10.1186/s12883-024-03957-w","url":null,"abstract":"","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"443"},"PeriodicalIF":2.2,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558832/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electroencephalography based delirium screening in acute supratentorial stroke. 基于脑电图的急性上脑卒中谵妄筛查。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-13 DOI: 10.1186/s12883-024-03942-3
Gesine Hermann, Friederike Baumgarte, Julius Welzel, Peter Nydahl, Gregor Kuhlenbäumer, Nils Gerd Margraf

Background: Up to 25% of patients suffering from an acute stroke are diagnosed with delirium during the hospital stay, with older age increasing the risk. Generalized slowing in the electroencephalogram (EEG) supports the diagnosis of delirium. We examined the potential of single-channel EEG (DeltaScan®) as an easy-to-use device on intensive care units for detecting delirium. Our aim was to investigate characteristics of bihemispheric EEG recordings and single-channel EEG in patients suffering from strokes with and without delirium and to analyze the diagnostic accuracy of EEG-based diagnoses.

Methods: Within the first five days after stroke onset, patients received single-channel EEG DeltaScan® and a routine 21-channel EEG. The DeltaScan® analyzes right sided fronto-parietal EEG using a proprietary algorithm focusing on polymorphic delta activity (PDA). In routine EEG the power spectral density (PSD) in predefined frequency bands was analyzed based on 2-minute eyes-closed resting state segments. EEG-analyses were conducted in MNE (v1.3.1) in Python (3.10) and RStudio (v4.2.1).

Results: In 9 of 53 patients (52-90 years) delirium was diagnosed according to DSM-V criteria. Sensitivity of DeltaScan® was 44% (95% CI = 15.3-77.3%), while specificity was 71% (95% CI = 57-83%). We found patients with right hemispheric stroke having a higher probability to be false positive in DeltaScan® (p = 0.01). The 21-channel EEG based power analysis revealed significant differences in frontal delta and theta power between patients with and without delirium (p < 0.05).

Conclusions: When EEG is used in clinical practice to support a delirium diagnosis in stroke patients, bihemispheric recordings are likely preferable over unilateral recordings. Slowing in the delta- or theta-frequency spectrum over the site of stroke may lead to false-positive results in single channel EEG based delirium scoring.

背景:多达 25% 的急性中风患者在住院期间被诊断为谵妄,年龄越大,风险越高。脑电图(EEG)的普遍减慢有助于谵妄的诊断。我们研究了单通道脑电图(DeltaScan®)作为重症监护病房检测谵妄的易用设备的潜力。我们的目的是研究有谵妄和无谵妄的脑卒中患者的双半球脑电图记录和单通道脑电图的特征,并分析基于脑电图诊断的准确性:在脑卒中发病后的头五天内,患者接受了单通道脑电图 DeltaScan® 和常规 21 通道脑电图检查。DeltaScan® 采用专有算法分析右侧前顶叶脑电图,重点是多态三角活动 (PDA)。在常规脑电图中,根据 2 分钟闭眼静息状态片段分析预定频段的功率谱密度 (PSD)。脑电图分析在 Python (3.10) 和 RStudio (v4.2.1) 的 MNE (v1.3.1) 中进行:53 名患者(52-90 岁)中有 9 人根据 DSM-V 标准被诊断为谵妄。DeltaScan® 的灵敏度为 44% (95% CI = 15.3-77.3%),特异度为 71% (95% CI = 57-83%)。我们发现右半脑卒中患者在 DeltaScan® 中出现假阳性的概率较高(p = 0.01)。基于 21 通道脑电图的功率分析显示,有谵妄和无谵妄患者的额叶 delta 和 theta 功率存在显著差异(p 结论:谵妄和无谵妄患者的额叶 delta 和 theta 功率存在显著差异:在临床实践中使用脑电图支持脑卒中患者的谵妄诊断时,双半球记录可能优于单侧记录。中风部位的δ或θ频谱减慢可能导致基于单通道脑电图的谵妄评分出现假阳性结果。
{"title":"Electroencephalography based delirium screening in acute supratentorial stroke.","authors":"Gesine Hermann, Friederike Baumgarte, Julius Welzel, Peter Nydahl, Gregor Kuhlenbäumer, Nils Gerd Margraf","doi":"10.1186/s12883-024-03942-3","DOIUrl":"10.1186/s12883-024-03942-3","url":null,"abstract":"<p><strong>Background: </strong>Up to 25% of patients suffering from an acute stroke are diagnosed with delirium during the hospital stay, with older age increasing the risk. Generalized slowing in the electroencephalogram (EEG) supports the diagnosis of delirium. We examined the potential of single-channel EEG (DeltaScan<sup>®</sup>) as an easy-to-use device on intensive care units for detecting delirium. Our aim was to investigate characteristics of bihemispheric EEG recordings and single-channel EEG in patients suffering from strokes with and without delirium and to analyze the diagnostic accuracy of EEG-based diagnoses.</p><p><strong>Methods: </strong>Within the first five days after stroke onset, patients received single-channel EEG DeltaScan<sup>®</sup> and a routine 21-channel EEG. The DeltaScan<sup>®</sup> analyzes right sided fronto-parietal EEG using a proprietary algorithm focusing on polymorphic delta activity (PDA). In routine EEG the power spectral density (PSD) in predefined frequency bands was analyzed based on 2-minute eyes-closed resting state segments. EEG-analyses were conducted in MNE (v1.3.1) in Python (3.10) and RStudio (v4.2.1).</p><p><strong>Results: </strong>In 9 of 53 patients (52-90 years) delirium was diagnosed according to DSM-V criteria. Sensitivity of DeltaScan<sup>®</sup> was 44% (95% CI = 15.3-77.3%), while specificity was 71% (95% CI = 57-83%). We found patients with right hemispheric stroke having a higher probability to be false positive in DeltaScan<sup>®</sup> (p = 0.01). The 21-channel EEG based power analysis revealed significant differences in frontal delta and theta power between patients with and without delirium (p < 0.05).</p><p><strong>Conclusions: </strong>When EEG is used in clinical practice to support a delirium diagnosis in stroke patients, bihemispheric recordings are likely preferable over unilateral recordings. Slowing in the delta- or theta-frequency spectrum over the site of stroke may lead to false-positive results in single channel EEG based delirium scoring.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"442"},"PeriodicalIF":2.2,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11558914/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete excision of a giant chondrosarcoma within the cavernous sinus: a case report and literature review. 完全切除海绵窦内的巨大软骨肉瘤:病例报告和文献综述。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-11 DOI: 10.1186/s12883-024-03944-1
Wenhui Zhang, Lihao Lin, Xuan Chen, Yubo Wang, Yongxue Li, Yan Wang, Yi Guan

Background: Primary skull base chondrosarcoma (SBC) is a rare malignant central nervous system tumor, often involving the cavernous sinus. Complete excision of tumors invading this region is exceptionally challenging due to the presence of the internal carotid artery and numerous nerves within the cavernous sinus, particularly in cases with substantial tumor volume.

Case presentation: This report describes a rare case of a massive primary SBC pushing the lateral wall of the cavernous sinus, measuring approximately 6.6 cm × 4.5 cm × 4.4 cm. Utilizing neurophysiological monitoring and intraoperative navigation, we successfully achieved complete tumor resection along the membranous structure via a left modified pterional approach (pterional-zygomatic arch-subdural-infratemporal approach), employing tools such as a cavitron ultrasonic surgical aspirator (CUSA) and piezosurgery. During the excision, localized rupture and bleeding of the internal carotid artery occurred, but prompt repair and anastomosis were performed. Postoperatively, the patient's symptoms markedly improved, and good reperfusion of the internal carotid artery was observed without new severe complications. The postoperative pathological diagnosis, according to the World Health Organization classification, was Grade 1 chondrosarcoma; therefore, radiotherapy was not administered. Magnetic resonance imaging at the 8-month follow-up showed no residual tumor or recurrence.

Conclusions: This case highlights that surgical complete excision of large intracavernous SBCs, while preserving vital neurovascular functions, is feasible and paramount for achieving favorable outcomes, particularly for Grade 1 and 2 SBCs, which comprise 82.4% of all subtypes. The use of a modified left pterional approach, intra-capsular tumor resection techniques, alongside CUSA and piezosurgery, provides valuable insights and serves as a reference for achieving complete excision of SBCs within the cavernous sinus.

背景:原发性颅底软骨肉瘤(SBC)是一种罕见的恶性中枢神经系统肿瘤,常累及海绵窦。由于海绵窦内有颈内动脉和许多神经,特别是肿瘤体积较大的病例,因此完全切除侵犯该区域的肿瘤极具挑战性:本报告描述了一例罕见的巨大原发性海绵窦癌病例,该肿瘤压迫海绵窦外侧壁,大小约为 6.6 厘米 × 4.5 厘米 × 4.4 厘米。利用神经电生理监测和术中导航,我们通过左侧改良翼状入路(翼状-颧弓-硬膜下-颞底入路),采用腔内超声手术吸引器(CUSA)和压电手术等工具,成功沿膜结构完整切除了肿瘤。在切除过程中,颈内动脉局部破裂出血,但及时进行了修复和吻合。术后患者症状明显改善,颈内动脉再灌注良好,未出现新的严重并发症。根据世界卫生组织的分类,术后病理诊断为一级软骨肉瘤,因此没有进行放疗。8个月的随访磁共振成像显示没有残留肿瘤或复发:本病例突出表明,在保留重要神经血管功能的同时,手术完全切除海绵体内巨大的SBC是可行的,也是取得良好疗效的关键,尤其是1级和2级SBC,占所有亚型的82.4%。改良左翼切口、囊内肿瘤切除技术以及 CUSA 和压吸手术的使用为实现海绵窦内 SBC 的完全切除提供了宝贵的见解和参考。
{"title":"Complete excision of a giant chondrosarcoma within the cavernous sinus: a case report and literature review.","authors":"Wenhui Zhang, Lihao Lin, Xuan Chen, Yubo Wang, Yongxue Li, Yan Wang, Yi Guan","doi":"10.1186/s12883-024-03944-1","DOIUrl":"10.1186/s12883-024-03944-1","url":null,"abstract":"<p><strong>Background: </strong>Primary skull base chondrosarcoma (SBC) is a rare malignant central nervous system tumor, often involving the cavernous sinus. Complete excision of tumors invading this region is exceptionally challenging due to the presence of the internal carotid artery and numerous nerves within the cavernous sinus, particularly in cases with substantial tumor volume.</p><p><strong>Case presentation: </strong>This report describes a rare case of a massive primary SBC pushing the lateral wall of the cavernous sinus, measuring approximately 6.6 cm × 4.5 cm × 4.4 cm. Utilizing neurophysiological monitoring and intraoperative navigation, we successfully achieved complete tumor resection along the membranous structure via a left modified pterional approach (pterional-zygomatic arch-subdural-infratemporal approach), employing tools such as a cavitron ultrasonic surgical aspirator (CUSA) and piezosurgery. During the excision, localized rupture and bleeding of the internal carotid artery occurred, but prompt repair and anastomosis were performed. Postoperatively, the patient's symptoms markedly improved, and good reperfusion of the internal carotid artery was observed without new severe complications. The postoperative pathological diagnosis, according to the World Health Organization classification, was Grade 1 chondrosarcoma; therefore, radiotherapy was not administered. Magnetic resonance imaging at the 8-month follow-up showed no residual tumor or recurrence.</p><p><strong>Conclusions: </strong>This case highlights that surgical complete excision of large intracavernous SBCs, while preserving vital neurovascular functions, is feasible and paramount for achieving favorable outcomes, particularly for Grade 1 and 2 SBCs, which comprise 82.4% of all subtypes. The use of a modified left pterional approach, intra-capsular tumor resection techniques, alongside CUSA and piezosurgery, provides valuable insights and serves as a reference for achieving complete excision of SBCs within the cavernous sinus.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"438"},"PeriodicalIF":2.2,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Holocord syringomyelia caused by tethered cord syndrome: case report and literature review. 系索综合征引起的 Holocord 鞘膜积液:病例报告和文献综述。
IF 2.2 3区 医学 Q3 CLINICAL NEUROLOGY Pub Date : 2024-11-11 DOI: 10.1186/s12883-024-03951-2
Longtao Zheng, Zhangzheng Liao, Hongzhou Duan

Background: Syringomyelia is a rare disease with diverse etiologies, and the syrinx is typically confined to certain segments of the spinal cord. Case of syringomyelia affecting the whole cord due to tethered cord is extremely rare, and the underlying pathophysiological mechanisms remain poorly understood.

Case presentation: We described an 18-year-old male patient who presented with progressive weakness in both lower extremities and bladder dysfunction over the past four years. Magnetic resonance imaging (MRI) of the entire spine revealed a tethered spinal cord with a large syrinx extending from C1 to L5. Common causes of syrinx such as Chiari malformation, intramedullary tumors and spinal cord injury were systematically ruled out, leading to a strong suspicion that the tethered cord was the primary etiology of the extensive syringomyelia. After undergoing un-tethering surgery, the patient experienced significant symptomatic improvement, and the subsequent follow-up MRI examinations demonstrated a remarkable reduction and eventual resolution of the large syrinx.

Conclusions: Although rare, tethered cord syndrome can serve as the sole etiology for extensive syringomyelia. For such patients, performing un-tethering surgery can lead to complete resolution of the syrinx and achieve a satisfactory clinical outcome.

背景:鞘膜积液是一种罕见疾病,病因多种多样,鞘膜积液通常局限于脊髓的某些节段。因脊髓拴系而影响整条脊髓的鞘膜积液病例极为罕见,其潜在的病理生理机制仍鲜为人知:我们描述了一名 18 岁的男性患者,他在过去四年中出现了进行性双下肢无力和膀胱功能障碍。整个脊柱的磁共振成像(MRI)显示脊髓拴系,一个巨大的鞘膜从 C1 延伸至 L5。系统排除了常见的鞘膜积液病因,如Chiari畸形、髓内肿瘤和脊髓损伤,因此强烈怀疑系带是造成广泛鞘膜积液的主要病因。在接受解拴手术后,患者的症状得到了明显改善,随后的磁共振成像检查显示大面积鞘膜积液显著减少并最终消失:结论:系索综合征虽然罕见,但可作为广泛性鞘膜积液的唯一病因。结论:系索综合征虽然罕见,但可作为广泛性鞘膜积液的唯一病因,对此类患者实施解系手术可导致鞘膜积液完全消退,并获得满意的临床疗效。
{"title":"Holocord syringomyelia caused by tethered cord syndrome: case report and literature review.","authors":"Longtao Zheng, Zhangzheng Liao, Hongzhou Duan","doi":"10.1186/s12883-024-03951-2","DOIUrl":"10.1186/s12883-024-03951-2","url":null,"abstract":"<p><strong>Background: </strong>Syringomyelia is a rare disease with diverse etiologies, and the syrinx is typically confined to certain segments of the spinal cord. Case of syringomyelia affecting the whole cord due to tethered cord is extremely rare, and the underlying pathophysiological mechanisms remain poorly understood.</p><p><strong>Case presentation: </strong>We described an 18-year-old male patient who presented with progressive weakness in both lower extremities and bladder dysfunction over the past four years. Magnetic resonance imaging (MRI) of the entire spine revealed a tethered spinal cord with a large syrinx extending from C1 to L5. Common causes of syrinx such as Chiari malformation, intramedullary tumors and spinal cord injury were systematically ruled out, leading to a strong suspicion that the tethered cord was the primary etiology of the extensive syringomyelia. After undergoing un-tethering surgery, the patient experienced significant symptomatic improvement, and the subsequent follow-up MRI examinations demonstrated a remarkable reduction and eventual resolution of the large syrinx.</p><p><strong>Conclusions: </strong>Although rare, tethered cord syndrome can serve as the sole etiology for extensive syringomyelia. For such patients, performing un-tethering surgery can lead to complete resolution of the syrinx and achieve a satisfactory clinical outcome.</p>","PeriodicalId":9170,"journal":{"name":"BMC Neurology","volume":"24 1","pages":"439"},"PeriodicalIF":2.2,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11552217/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142614957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BMC Neurology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1